NEXTBio Capital Management’s ADARx Pharmaceuticals, Inc. Common Stock ADRX Stock Holding History
Bought
Maintained
Sold
Other funds holding ADRX
SL
NEXTBio Capital Management's ADRX Position: Q3 2026 in Review
NEXTBio Capital Management opened a new position in ADARx Pharmaceuticals, Inc. Common Stock (ADRX) in Q3 2026: 100,000 shares worth $1.99M. The stake represents 0.85% of the portfolio and ranks #23 among its holdings.
26 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.
- NEXTBio Capital Management held 100,000 shares of ADARx Pharmaceuticals, Inc. Common Stock worth $1.99M as of Q3 2026.
- ADARx Pharmaceuticals, Inc. Common Stock was a new NEXTBio Capital Management position in Q3 2026.
- ADARx Pharmaceuticals, Inc. Common Stock made up 0.85% of NEXTBio Capital Management's portfolio in Q3 2026, its #23 holding.
- 26 funds tracked by Wall St. Rank held ADARx Pharmaceuticals, Inc. Common Stock as of Q3 2026.
Based on NEXTBio Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.